Effectiveness and safety of ixazomib–lenalidomide–dexamethasone in high-cytogenetic-risk relapsed/refractory multiple myeloma — results of the Polish Myeloma Group observational study
M. Hus, A. Szudy-Szczyrek, Michał Mielnik, P. Bernatowicz, J. Piszcz, A. Druzd-Sitek, Maria Czyżewska, Maciej Putowski, K. Giannopoulos
{"title":"Effectiveness and safety of ixazomib–lenalidomide–dexamethasone in high-cytogenetic-risk relapsed/refractory multiple myeloma — results of the Polish Myeloma Group observational study","authors":"M. Hus, A. Szudy-Szczyrek, Michał Mielnik, P. Bernatowicz, J. Piszcz, A. Druzd-Sitek, Maria Czyżewska, Maciej Putowski, K. Giannopoulos","doi":"10.5603/HCP.2021.0002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12837,"journal":{"name":"Haematologia","volume":"1 1","pages":"8-17"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haematologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/HCP.2021.0002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
